From Health Plan Week - Health insurers are on the defensive over the way some provider networks for public exchanges are designed, leading to criticism that consumers buying coverage on the new marketplaces don’t have access to out-of-network care. Read more
From Health Plan Week - FDA’s December 2013 approval of hepatitis C drug Sovaldi (sofosbuvir) has rattled health insurers, PBMs and state Medicaid programs, causing “near panic” with some plans because of the drug’s expense, its potential demographic reach and the timing of its market entry. Read more
From Health Plan Week - Health insurers say they are working, consultants say they are in an evolutionary stage and researchers say they just don’t have enough data yet to declare if they are achieving their goals. Read more
Check out all of the benefits, sample issues & more!